• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Anthera Pharmaceuticals Inc

+ Add to Watchlist

6TA1:GR

2.107 EUR 0.028 1.31%

As of 02:10:40 ET on 04/24/2014.

Snapshot for Anthera Pharmaceuticals Inc (6TA1)

Open: 2.091 Day's Range: 2.091 - 2.107 Volume: 0
Previous Close: 2.135 52wk Range: 1.952 - 3.512 1-Yr Rtn: -35.76%

Stock Chart for 6TA1

No chart data available.
  • 6TA1:GR 2.091
  • 1D
  • 1M
  • 1Y
2.135
Interactive 6TA1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 6TA1

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.6740
Est. PEG Ratio -
Market Cap (M EUR) 42.19
Shares Outstanding (M) 20.02
30 Day Average Volume 672
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 6TA1

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 6TA1

Anthera Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing anti-inflammatory therapeutics for cardiovascular diseases, lupus and other serious diseases.

Christopher S HenneyChairmanPaul F TruexPresident/CEO/Founder
Debra OdinkSenior VP/CTOColin HislopSenior VP/Chief Medical Ofcr
More Company Profile & Key Executives for 6TA1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil